LAS VEGAS -- Skinvisible, Inc. announces that its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc. has reached an agreement with the University of Nevada, Las Vegas (UNLV), to supply its athletic department with its patented antimicrobial skin sanitizer lotion to help prevent the spread of methicillin-resistant Staphylococcus aureus (MRSA), a skin-infection bacteria that is increasingly affecting athletes.
UNLV is the first college athletic facility to use the Skinvisible product, making it available to approximately 500 student athletes who train and compete at the university on a daily basis.
"We are very pleased to have been introduced to this new product," says UNLV Athletic Trainer Kyle Wilson. "We feel it is important to take a proactive approach in the prevention to the spread of infectious germs, including MRSA, amongst our student athletes. We're confident that this product can help us achieve that goal."
"Independent studies conclude that the Skinvisible skin sanitizer, which is formulated with Triclosan as the active ingredient, demonstrates a superior bacteriostatic and/or bactericidal effect against a broad spectrum of test pathogens, including MRSA," reports Dr. James Roszell, head chemist at Skinvisible. "When topically applied, independent studies verify that this lotion delivers a continuous, long-term bacterial kill of up to 99.9 percent for up to four hours per application, which is undiminished by hand washing or perspiration."
In a recent USA Today article, reporter Gary Mihoces notes several cases of MRSA among high school, college and professional sports teams. In September 2003, several members of the NFL's Miami Dolphins were infected by MRSA. As well, the Center for Disease Control and Prevention (CDC) reports that a fencing club in Colorado, a college football team in Pennsylvania and a number of high school wrestlers in Indiana, have recently been hit by MRSA. The report concludes that the spread of MRSA is a growing concern among the general population.
"Skinvisible is proud to have UNLV be the first to offer our product to their student athletes and we look forward to introducing our product to other schools and athletic organizations across the country," says Terry Howlett, CEO of Skinvisible, Inc.
Headquartered in Las Vegas, Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions.
Source: Skinvisible, Inc.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.